Clinical Trial Update: A Phase 1 Dose Escalation Study of VX-973 in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study of VX-973 in healthy participants has completed, with Vertex Pharmaceuticals investigating safety and pharmacokinetics in the co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• VX-973

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Pain | Phase 1 | Status: COMPLETED